Neck pain
Drug research and approvals for neck pain: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 211 studies of neck pain are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 2 approved and 0 open orphan designations naming it.
- Recruiting worldwide: 211
- Trials authorized in Canada: 0
- FDA orphan approvals: 2
- EU medicines: 0
- Thoracic Mobilization Versus Thoracic Strengthening for Chronic Mechanical Neck PainNCT07949565 · Not applicable · Ibadat International University, Islamabad · starts Jul 5, 2026
- Effects of Cervicothoracic Junction Manipulation Among Chronic Neck PainNCT07945847 · Not applicable · Riphah International University · starts Nov 10, 2026
- Effects of Alexander Technique Versus Feldenkrais Somatic Training in Patients With Text Neck SyndromeNCT07921004 · Not applicable · Riphah International University · starts Oct 28, 2026
- Strain Counter Strain and Conventional Stretching in School-aged Children With Mechanical Neck Pain Due to Prolong…NCT07920978 · Not applicable · Riphah International University · starts Jul 1, 2026
- Effectiveness of Phenotype-based Pain Management Guidelines for Head and Neck Cancer Related Pain: a Pilot StudyNCT07919444 · Phase 2 · Shaukat Khanum Memorial Cancer Hospital & Research Centre · starts Feb 26, 2025
- Phenotype-based Model for Managing Chronic Post-treatment Pain Among Head and Neck Cancer Survivors: a Pilot StudyNCT07919457 · Phase 2 · Shaukat Khanum Memorial Cancer Hospital & Research Centre · starts Jul 16, 2026
- Correlation Between Forward Head Posture and Executive Functions in Cervical RadiculopathyNCT07906847 · Not reported · Cairo University · starts Nov 4, 2026
- Upper Extremity Exercise Capacity in Chronic Non-specific Neck PainNCT07899879 · Not reported · Karabuk University · starts May 30, 2026
- Effects of Instrument-Assisted Soft Tissue Mobilization Versus Post Facilitation Stretch Technique in Chronic Neck PainNCT07887698 · Not applicable · Foundation University Islamabad · starts Feb 12, 2026
Phase 3 4
- IbuprofenCyclooxygenase inhibitor
- OxycodoneMu opioid receptor agonist
- CaffeineAdenosine receptor antagonist
- Cannabinol
Phase 2 6
- AcetaminophenCyclooxygenase inhibitor
- CodeineOpioid receptors; mu/kappa/delta agonist
- VenlafaxineSerotonin transporter inhibitor
- DexamethasoneGlucocorticoid receptor agonist
- LoxoprofenCyclooxygenase inhibitor
- Carbon dioxide
Phase 1 or earlier 1
- MidazolamGABA-A receptor; anion channel positive allosteric modulator
How its trials ended
1,013 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 91 whose ending is known, 62% met their primary endpoint, 10% missed it and 29% stopped early.
- Completed, result not reported59959%
- Ongoing18919%
- Status unknown13413%
- Met its primary endpoint566%
- Stopped: other or unclear212%
- Missed its primary endpoint91%
- Stopped: enrollment or feasibility5<1%
| Dec 21, 2000 | BotoxTreatment of cervical dystonia in adults to decrease the severity of abnormal head position and neck pain associated with cervical dystonia. | Allergan, Inc. | Approved |
| Dec 8, 2000 | MyoblocTreatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical… | Soltice Neurosciences, LLC | Approved |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA